Home » Advisory reports » Page 3

Advisory reports

  • 05-11-2025

    Advice Import and processing of GM maize Bt11 x MIR162 x MON89034 x NK603 and its subcombinations

    The present application, GMFF-2025-33624 (MA 250015_001), concerns the authorisation ...

    Advisory reports
    CGM/251105-02 View more
  • 05-11-2025

    Advice on the import and processing of GM maize MZIR260

    COGEM was asked to advise on the potential environmental risks of import and processi...

    Advisory reports
    CGM/251105-01 View more
  • 04-11-2025

    Advice on the import and processing of GM soybean DAS-44406-6 x FG72

    COGEM was asked to advise on the potential environmental risks of import and processi...

    Advisory reports
    CGM/251104-01 View more
  • 19-08-2025

    Advice Explanation of the COGEM formula for calcu­lating free lentiviral or gammaretroviral vector particles after ex vivo transduction

    In biomedical or clinical research, cells are often genetically modified using lentiv...

    Advisory reports
    CGM/250819-01 View more
  • 15-03-2023

    Environmental risk assessment of import and processing of insect resistant and herbicide tolerant GM maize DAS1131

    The present application (GMFF-2021-1530) concerns the authorisation for import and pr...

    Advisory reports
    CGM/230315-01 View more
  • 28-07-2025

    Advice on the renewal of the import and processing of GM soybean FG72

    The present application concerns the authorisation of genetically modified (GM) soy F...

    Advisory reports
    CGM/250728-02 View more
  • 11-03-2025

    Advice on generic containment measures for activities involving arthropod biological control agents in PKb-I research greenhouses

    Biological control agents may be introduced into greenhouses and growth chambers wher...

    Advisory reports
    CGM/250311-02 View more
  • 20-05-2025

    Advice Reassessment of the threshold values for the presence of free lentiviral and retroviral vector particles in clinical trials with ex vivo transduced cells

    In certain gene therapies, cells from the patient are genetically altered outside the...

    Advisory reports
    CGM/250520-01 View more
  • 30-04-2025

    Advice on tightening conditions for generic downscaling of containment requirements for the use of transgenes in alphavirus replicons

    In 2022 COGEM advised that laboratory work with viral replicons derived from alphavir...

    Advisory reports
    CGM/250430-01 View more
  • 15-05-2025

    Advice Environmental risk assessment of import and processing of GM maize Bt11 x MIR162 x MZIR098 x DP4114 x NK603 and its subcombinations

    The present application (GMFF-2024-22152) concerns the authorisation of genetically m...

    Advisory reports
    CGM/250515-04 View more